SCHEMBL4267580

SCHEMBL4267580

COC(=O)c1ccc(CN2CCN(C)CC2)c(C)c1

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.57
CHKA P35790 1/20 0.55
HDAC6 Q9UBN7 1/20 0.47
KIT P10721 2/20 0.46
ALDH1A1 P00352 7/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
KDM4E B2RXH2 4/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
GAA P10253 2/20 0.45
LMNA P02545 2/20 0.45
HSD17B10 Q99714 3/20 0.45
ALOX12 P18054 1/20 0.45
MAPK1 P28482 1/20 0.45
HRH3 Q9Y5N1 1/20 0.44
HPGD P15428 1/20 0.44
ALOX15 P16050 1/20 0.44
CASP1 P29466 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18854071 0.89 CHKA (0.55) MAPTCHKAHDAC6KITALDH1A1
SCHEMBL16335558 0.89 MAPT (0.57) MAPTCHKAALDH1A1MEN1KMT2A
SCHEMBL6171317 0.89 MAPT (0.57) MAPTCHKAALDH1A1MEN1KMT2A
SCHEMBL28046507 0.88 MAPT (0.46) MAPTCHKAHDAC6KITALDH1A1
SCHEMBL9939410 0.85 CHKA (0.57) MAPTCHKAHDAC6ALDH1A1MEN1
SCHEMBL15847254 0.85 CHKA (0.54) MAPTCHKAHDAC6KITALDH1A1
SCHEMBL18775267 0.85 ALDH1A1 (0.55) MAPTHDAC6KITALDH1A1KDM4E
SCHEMBL4702839 0.83 ALDH1A1 (0.49) MAPTHDAC6KITALDH1A1KDM4E
Hydrochloric Acid SCHEMBL4273434 0.83 ALDH1A1 (0.54) MAPTHDAC6KITALDH1A1MEN1
SCHEMBL17982817 0.83 L3MBTL1 (0.60) CHKAALDH1A1MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170349588-A1 1H-1,8-NAPHTHYRIDIN-2-ONES AS ANTI PROLIFERATIVE COMPOUNDS NATCO PHARMA LIMITED (IN) 2017-12-07 US disclosed
US-9765072-B2 1H-1,8-naphthyridin-2ones as anti proliferative compounds NATCO PHARMA LIMITED (US) 2017-09-19 US disclosed
US-20170114057-A1 1H-1,8-NAPHTHYRIDIN-2ONES AS ANTI PROLIFERATIVE COMPOUNDS NATCO PHARMA LIMITED (IN) 2017-04-27 US disclosed
EP-1533304-B1 AMIDE DERIVATIVE NIPPON SHINYAKU CO LTD (JP) 2009-11-04 EP disclosed
US-7494997-B2 Amide derivative NIPPON SHINYAKU CO., LTD. (JP) 2009-02-24 US disclosed
CN-100343237-C Amide derivative and medicine NIPPON SHINYAKU CO LTD (JP) 2007-10-17 CN disclosed
US-20060014742-A1 Amide derivative NIPPON SHINYAKU CO., LTD. (JP) 2006-01-19 US disclosed
CN-1678590-A Amide derivative and pharmaceutical NIPPON SHINYAKU CO LTD (JP) 2005-10-05 CN disclosed
EP-1533304-A1 AMIDE DERIVATIVE Nippon Shinyaku Co., Ltd. (JP) 2005-05-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170349588-A1 1H-1,8-NAPHTHYRIDIN-2-ONES AS ANTI PROLIFERATIVE COMPOUNDS ABL1, MKI67, MCL1 MAPT 3385/4885CHKA 1214/4885HDAC6 1240/4885
US-20060014742-A1 Amide derivative ABL1, ABL2, BCR MAPT 4801/4885CHKA 670/4885HDAC6 1149/4885
US-20170114057-A1 1H-1,8-NAPHTHYRIDIN-2ONES AS ANTI PROLIFERATIVE COMPOUNDS ABL1, MKI67, ABL2 MAPT 3570/4885CHKA 1068/4885HDAC6 1275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.